In the spotlight: Nestle's Pfizer buy offers long-term baby food boost
Nestle has won through in the battle to acquire Pfizer's baby food business, securing an US$11.85bn deal that will see the world's largest infant nutrition group extend its lead in this fast-growing category. However, with a hefty price tag attached, the deal has not been warmly welcomed by investors. Katy Askew reports.
Get full access to all content, just $1 for 30 days
A Message From The Editor
just-food gives you the widest food market coverage.
Paid just-food members have unlimited access to all our exclusive content - including 16 years of archives.
I am so confident you will love complete access to our content that today I can offer you 30 days access for $1.
It’s our best ever membership offer – just for you.
Dean Best, editor of just-food
- How Hormel Foods can benefit from Justin's
- Tackling infant formula fraud in China
- Colian hungry for international growth - interview
- How discounters unsettling Australia's food sector
- Why trust is key in US natural food sector
- US food labels to include "added sugars" info
- General Mills invests in another US SME
- ABP Food Group names COO Frank Stephenson new CEO
- Kraft Heinz to expand US plant
- Dairy Crest to focus on brands, ingredients